Neurocysticercosis: A major aetiological factor of late-onset epilepsy in Madagascar

Tropical Medicine and International Health

Volumn 2, Issue 8, 1997, Pages 741-746

  Andriantsimahavandy, A ^a   Lesbordes, J L ^b   Rasoaharimalala, B ^b   Peghini, M ^b   Rabarijaona, L ^a   Roux, J ^a   Boisier, P ^a  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b Centre Hospitalier Soavinandriana   (Madagascar)

Author keywords

cysticercosis; enzyme linked immunoelectrotransfer blot; late onset epilepsy; Madagascar; population attributable risk percent

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; IMMUNOBLOTTING; MADAGASCAR; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; SERUM; SOCIAL STATUS; TAENIA SOLIUM;

TAENIA SOLIUM;

EID: 0030849830     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1997.d01-379.x     Document Type: Article

References (21)

1. Andriamiandra A, Cros J, Dodin A & Brygoo ER (1969) La cysticercose à Madagascar. Bulletin de la Société de Pathologie Exotique 62, 894-900.
2. Andrianjafy (1910) Cysticercose humaine. Bulletin de la Société des Sciences Médicales de Madagascar 2, 53-60.
3. Brygoo ER & Dodin A (1963) Les helminthes parasites de l'homme en pratique histopathologique courante à Madagascar. II - Cysticercus cellulosae à propos de 59 observations. Archives de l'Institut Pasteur de Madagascar 32, 37-45.
4. Coughlin SS, Benichou J & Weed DL (1994) Attributable Risk Estimation in Case-Control Studies. Epidemiologic Reviews 16, 51-64.
5. Dansey RD, Hay M & Cowie RL (1991) Seizures and neurocysticercosis in black men. South African Medical Journal 81, 424-425.
6. Diaz JF, Verastegui M, Gilman RH, et al. (1992.) Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. American Journal of Tropical Medicine and Hygiene 46, 610-615.
7. Dumas M, Grunitzky K, Belo M, et al. (1990) Cysticercose et neurocysticercose: enquête épidémiologique dans le nord du Togo. Bulletin de la Société de Pathologie Exotique 83, 263-274.
8. Garcia HH, Gilman R, Martinez M, et al. (1993) Cysticercosis as a major cause of epilepsy in Peru. Lancet 341, 197-200.
9. Grill J, Rakotomalala W, Andriantsimahavandy A, et al. (1996) High prevalence of serological markers of cysticercosis among epileptic Malagasy children. Annals of Tropical Paediatrics 16, 185-191.
10. Kuritz SJ & Landis JR (1987) Attributable risk ratio estimation from matched-pairs case-control data. American Journal of Epidemiology 125, 324-328.
11. Medina MT, Rosas E, Rubio-Donnadieu F & Sotelo J (1990) Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Archives of Internal Medicine 150, 325-327.
12. Michel P, Callies P, Raharison H, Guyon P, Holvoet L & Genin G (1993) Epidémiologie de la cysticercose à Madagascar. Bulletin de la Société de Pathologie Exotique 86, 62-67.
13. Monteiro L, Coelho T & Stocker A (1992) Neurocysticercosis - A review of 231 cases. Infection 20, 61-65.
14. Senanayake N & Roman GC (1993) Epidemiology of epilepsy m developing countries. Bulletin of the World Health Organization 71, 247-258.
15. Shandera WX, White AC, Chen JC, Diaz P & Armstrong R (1994) Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine 73, 37-52.
16. Simac C, Michel P, Andriantsimahavandy A, Esterre P & Michault A (1995) Use of enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot for the diagnosis and monitoring of neurocysticercosis. Parasitology Research 81, 132-136.
17. The Commission on Classification and Terminology of the International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 21, 489-501.
18. Thomson AJG (1993) Neurocysticercosis - experience at the teaching hospitals of the University of Cape Town. South African Medical Journal 83, 332-334.
19. Van As AD & Joubert J (1991) Neurocysticercosis in 578 black epileptic patients. South African Medical Journal 80, 317-328.
20. WHO (1981) Research protocol for measuring the prevalence of neurological disorders in developing countries. Neurosciences programme. Geneva: World Health Organization.
21. Wilson M, Bryan RT, Fried JA, et al. (1991) Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer Mot in patients with neurocysticercosis. Journal of Infectious Diseases 164, 1007-1009.